Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fibrodynamics-elucidation of the mechanisms and sites of liver fibrogenesis.

Literature DB >> 11819474

Fibrodynamics-elucidation of the mechanisms and sites of liver fibrogenesis.

Catherine H Wu.

Abstract

Year: 1999 PMID： 11819474 PMCID： PMC4688606 DOI： 10.3748/wjg.v5.i5.388

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

× No keyword cloud information.

37 in total

Review 1. Hepatic fibrosis.

Authors: M Rojkind; D Kershenobich
Journal: Prog Liver Dis Date: 1976

2. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.

Authors: C Hellerbrand; C Jobin; Y Iimuro; L Licato; R B Sartor; D A Brenner
Journal: Hepatology Date: 1998-05 Impact factor: 17.425

3. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.

Authors: S L Friedman; M J Arthur
Journal: J Clin Invest Date: 1989-12 Impact factor: 14.808

4. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

Authors: M Pinzani; L Gesualdo; G M Sabbah; H E Abboud
Journal: J Clin Invest Date: 1989-12 Impact factor: 14.808

5. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Authors: N Sanderson; V Factor; P Nagy; J Kopp; P Kondaiah; L Wakefield; A B Roberts; M B Sporn; S S Thorgeirsson
Journal: Proc Natl Acad Sci U S A Date: 1995-03-28 Impact factor: 11.205

6. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Authors: W A Border; N A Noble; T Yamamoto; J R Harper; Y u Yamaguchi; M D Pierschbacher; E Ruoslahti
Journal: Nature Date: 1992-11-26 Impact factor: 49.962

7. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.

Authors: Y Isaka; D K Brees; K Ikegaya; Y Kaneda; E Imai; N A Noble; W A Border
Journal: Nat Med Date: 1996-04 Impact factor: 53.440

8. Propeptide-mediated regulation of procollagen synthesis in IMR-90 human lung fibroblast cell cultures. Evidence for transcriptional control.

Authors: C H Wu; C M Walton; G Y Wu
Journal: J Biol Chem Date: 1991-02-15 Impact factor: 5.157

9. Immunogold localization of procollagen III, fibronectin and heparan sulfate proteoglycan on ultrathin frozen sections of the normal rat liver.

Authors: A Geerts; H J Geuze; J W Slot; B Voss; D Schuppan; P Schellinck; E Wisse
Journal: Histochemistry Date: 1986

10. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis.

Authors: W R Jarnagin; D C Rockey; V E Koteliansky; S S Wang; D M Bissell
Journal: J Cell Biol Date: 1994-12 Impact factor: 10.539

10 in total

1. Plasma endothelin in patients with endotoxemia and dynamic comparison between vasoconstrictor and vasodilator in cirrhotic patients.

Authors: F Liu; J X Li; C M Li; X S Leng
Journal: World J Gastroenterol Date: 2001-02 Impact factor: 5.742

Fibrodynamics-elucidation of the mechanisms and sites of liver fibrogenesis.

Review 1. Hepatic fibrosis.

2. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.

3. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.

4. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

5. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

6. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

7. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.

8. Propeptide-mediated regulation of procollagen synthesis in IMR-90 human lung fibroblast cell cultures. Evidence for transcriptional control.

9. Immunogold localization of procollagen III, fibronectin and heparan sulfate proteoglycan on ultrathin frozen sections of the normal rat liver.

10. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis.

1. Plasma endothelin in patients with endotoxemia and dynamic comparison between vasoconstrictor and vasodilator in cirrhotic patients.

2. CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis.

3. Effects of Yigan Decoction on proliferation and apoptosis of hepatic stellate cells.

4. Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation.

5. Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4).

6. Estrogen reduces CCL4- induced liver fibrosis in rats.

7. Protective effect of estradiol on hepatocytic oxidative damage.

8. Effects of estradiol on liver estrogen receptor-alpha and its mRNA expression in hepatic fibrosis in rats.

9. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.

10. Effects of tetrandrine on calcium and potassium currents in isolated rat hepatocytes.